Effectiveness of the 2023-2024 Formulation of the COVID-19 Messenger RNA Vaccine.
Saved in:
| Title: | Effectiveness of the 2023-2024 Formulation of the COVID-19 Messenger RNA Vaccine. |
|---|---|
| Authors: | Shrestha NK; Department of Infectious Diseases, Cleveland Clinic, Cleveland, Ohio, USA., Burke PC; Infection Prevention, Cleveland Clinic, Cleveland, Ohio, USA., Nowacki AS; Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio, USA., Gordon SM; Department of Infectious Diseases, Cleveland Clinic, Cleveland, Ohio, USA. |
| Source: | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 Aug 16; Vol. 79 (2), pp. 405-411. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38465901 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Effectiveness of the 2023-2024 Formulation of the COVID-19 Messenger RNA Vaccine. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Shrestha+NK%22">Shrestha NK</searchLink>; Department of Infectious Diseases, Cleveland Clinic, Cleveland, Ohio, USA.<br /><searchLink fieldCode="AU" term="%22Burke+PC%22">Burke PC</searchLink>; Infection Prevention, Cleveland Clinic, Cleveland, Ohio, USA.<br /><searchLink fieldCode="AU" term="%22Nowacki+AS%22">Nowacki AS</searchLink>; Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio, USA.<br /><searchLink fieldCode="AU" term="%22Gordon+SM%22">Gordon SM</searchLink>; Department of Infectious Diseases, Cleveland Clinic, Cleveland, Ohio, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229203213%22">Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</searchLink> [Clin Infect Dis] 2024 Aug 16; Vol. 79 (2), pp. 405-411. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9203213 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1537-6591 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210584838%22">10584838 </searchLink><i>NLM ISO Abbreviation: </i>Clin Infect Dis <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38465901 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/cid/ciae132 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 405 Titles: – TitleFull: Effectiveness of the 2023-2024 Formulation of the COVID-19 Messenger RNA Vaccine. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Shrestha NK – PersonEntity: Name: NameFull: Burke PC – PersonEntity: Name: NameFull: Nowacki AS – PersonEntity: Name: NameFull: Gordon SM IsPartOfRelationships: – BibEntity: Dates: – D: 16 M: 08 Text: 2024 Aug 16 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1537-6591 Numbering: – Type: volume Value: 79 – Type: issue Value: 2 Titles: – TitleFull: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America Type: main |
| ResultId | 1 |
